[ENDP] Endo International plc

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 16.27 Change: 0.5 (3.17%)
Ext. hours: 16.25 Change: -0.02 (-0.12%)

chart ENDP

Refresh chart

Strongest Trends Summary For ENDP

ENDP is in the medium-term up 89% in 1 year. In the long-term down -74% below S&P in 2 years and down -96% below S&P in 9 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Endo International plc, a specialty healthcare company, develops, manufactures, markets, and distributes branded pharmaceutical and generic products, and medical devices worldwide. It provides branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar, and Fortesta Gel to treat and manage pain and conditions in urology, endocrinology, and oncology. The company also offers non-branded generic products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women?s health, and hypertension markets; and pharmaceutical products in the areas of ADHD, pain, urology, and allergy. In addition, it provides various medical devices comprising AMS 700 MS series, AMS 800 artificial urinary sphincters, GreenLight XPS laser systems, Elevate anterior and posterior pelvic floor repair systems, and Monarc subfascial hammock products in the areas of men?s and women?s health, and prostate health. The company?s products also inc

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y-1.55% Sales Growth - 4 Quarters -15.23% Sales Growth - Q/Q-10.73% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-2.55% ROE-8.7% ROI-3.62%
Current Ratio1.55 Quick Ratio1.37 Long Term Debt/Equity2.86 Debt Ratio0.83
Gross Margin49.62% Operating Margin-27.98% Net Profit Margin-11.54% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities Cash From Investing Activities996.86 M Cash From Operating Activities-930.48 M Gross Profit329.86 M
Net Profit-89.81 M Operating Profit45.75 M Total Assets14.15 B Total Current Assets5.33 B
Total Current Liabilities3.44 B Total Debt5.39 B Total Liabilities10.01 B Total Revenue714.13 M
Technical Data
High 52 week18.3 Low 52 week2.23 Last close3.49 Last change3.87%
RSI56.72 Average true range0.35 Beta0.74 Volume2.59 M
Simple moving average 20 days0.37% Simple moving average 50 days12.06% Simple moving average 200 days-43.02%
Performance Data
Performance Week-6.43% Performance Month-16.9% Performance Quart-0.29% Performance Half-53.59%
Performance Year-80.07% Performance Year-to-date-52.19% Volatility daily6.16% Volatility weekly13.76%
Volatility monthly28.21% Volatility yearly97.72% Relative Volume179.67% Average Volume7.95 M
New High New Low

News

2020-05-29 08:00:00 | Endo International plc Announces Early Tender Results Of Its Previously Announced Exchange Offers And Consent Solicitations

2020-05-27 12:56:10 | John Paulson Adds 2 Stocks to Portfolio, Boosts Tiffany

2020-05-14 17:00:00 | Endo to Participate at 2020 RBC Capital Markets Global Healthcare Virtual Conference

2020-05-14 11:46:11 | Endo Luxembourg Finance I Company S.a.r.l. -- Moody's downgrades Endo's 1st lien secured debt to B2; assigns Caa2 rating to new 2nd lien secured notes; B3 CFR affirmed

2020-05-14 07:38:00 | Endo International plc Announces Proposed Exchange Offers And Consent Solicitations

2020-05-13 10:05:23 | Was The Smart Money Right About Endo International plc ENDP?

2020-05-08 12:01:56 | Endo International ENDP Q1 2020 Earnings Call Transcript

2020-05-08 10:26:02 | Endo ENDP Q1 Earnings Beat on Coronavirus-Led Stockpiling

2020-05-07 19:11:58 | Edited Transcript of ENDP earnings conference call or presentation 7-May-20 12:00pm GMT

2020-05-07 15:11:00 | Endo International Fires on All Cylinders in Q1 Thanks to COVID-19 Impact

2020-05-07 09:53:18 | Endo International: Q1 Earnings Insights

2020-05-07 09:15:01 | Endo International ENDP Q1 Earnings and Revenues Top Estimates

2020-05-07 06:00:00 | Endo Reports First-Quarter 2020 Financial Results and Provides Update Relating to COVID-19 Pandemic

2020-05-01 09:26:00 | Will an Opioid Manufacturer Stage a Comeback With This New Venture?

2020-04-30 12:33:04 | Endo International ENDP Expected to Beat Earnings Estimates: Can the Stock Move Higher?

2020-04-16 17:00:00 | Endo to Announce First Quarter 2020 Financial Results

2020-04-14 12:10:04 | Why the Earnings Surprise Streak Could Continue for Endo ENDP

2020-04-07 09:46:00 | Covid-19 Could Bring Generic Drug Manufacturing Back to the U.S., Analyst Writes

2020-03-27 18:45:21 | Covid-19 Could Benefit Generic Drug Companies

2020-03-27 11:30:03 | Why Is Endo ENDP Down 33% Since Last Earnings Report?

2020-03-19 10:03:00 | The Coronavirus Outbreak Has Derailed Settlements in the Opioid Litigation

2020-03-06 10:06:03 | Implied Volatility Surging for Endo International ENDP Stock Options

2020-03-03 09:00:28 | These 3 Biotech Stocks Are Outperforming Their Peers — Here's Why

2020-03-02 08:26:24 | Does Market Volatility Impact Endo International plc's NASDAQ:ENDP Share Price?

2020-02-27 15:15:08 | Endo's ENDP Earnings & Revenues Trump Estimates in Q4

2020-02-26 23:44:40 | Edited Transcript of ENDP earnings conference call or presentation 26-Feb-20 1:00pm GMT

2020-02-26 07:35:12 | Endo International ENDP Q4 Earnings and Revenues Top Estimates

2020-02-26 06:08:44 | Drugmaker Endo posts smaller loss on asset impairment charges

2020-02-26 06:00:00 | Endo Reports Fourth-Quarter And Full-Year 2019 Financial Results

2020-02-26 06:00:00 | Endo International plc to Host Earnings Call

2020-02-20 13:26:44 | Endo International chooses a familiar face to be new CEO

2020-02-19 16:20:00 | Endo Names Blaise Coleman President and Chief Executive Officer

2020-02-19 16:20:00 | Endo Appoints Mark G. Barberio to Board of Directors

2020-02-19 12:31:05 | Earnings Preview: Endo International ENDP Q4 Earnings Expected to Decline

2020-02-12 10:55:30 | Small-Cap Healthcare ETF Outperforming in 2020: 5 Top Stocks

2020-01-27 17:20:10 | Here's Why You Should Add BioDelivery Stock to Your Portfolio

2020-01-27 16:20:00 | Endo Begins Shipment of Authorized Generic Version of Carafate® sucralfate Oral Suspension in the United States

2020-01-24 17:00:00 | Endo to Announce Fourth-Quarter and Full-Year 2019 Financial Results

2020-01-20 08:17:01 | J&J's $8B Jury Award in Risperdal Case Cut to $6.8M by Judge

2020-01-14 12:00:00 | Endo reaches $8.75M opioid settlement with Oklahoma

2020-01-13 09:11:02 | Endo Up on Opioid Abuse Settlement Agreement With Oklahoma

2020-01-10 15:09:00 | Endo settles opioid suit with Oklahoma AG

2020-01-10 11:50:00 | Endo Settles Opioid Investigation with State of Oklahoma for $8.75 million

2019-12-30 09:12:02 | Will J&J be Able to Overcome Its Legal Troubles in 2020?

2019-12-20 08:40:01 | Implied Volatility Surging for Endo ENDP Stock Options

2019-12-17 17:00:00 | Endo to Participate at J.P. Morgan Healthcare Conference

2019-12-10 08:06:00 | Endo Launches Generic Version of Afinitor® everolimus Tablets in the United States

2019-12-09 13:08:43 | Did Hedge Funds Drop The Ball On Endo International plc ENDP ?

2019-12-04 11:30:04 | Why Is Endo ENDP Up 12.3% Since Last Earnings Report?

2019-12-04 08:54:01 | Options Traders Expect Huge Moves in Endo ENDP Stock